glucagon like peptide 1 glp 1 agonists Glucagon-like in health and disease Frontiers | GLP−1 receptor agonists
Description
No injections needed just a daily tablet
The incretin system has become an important target in the treatment of type 2 diabetes in recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose-lowering effects
GLP-1 drugs could rapidly evolve beyond current use as diabetes and weight loss medications, with new research pointing to potential benefits in cancer, ageing, addiction, osteoarthritis and heart health
Records were reviewed for patient characteristics and medication type and doses
These compounds have demonstrated promise as natural glp 1 agonists and may complement dietary and lifestyle strategies for enhanced outcomes
